ロード中...
Formulation and Evaluation of Trimetazidine Dihydrochloride Extended Release Tablets by Melt Congealing Method
Trimetazidine dihydrochloride, a cellular antiischemic agent indicated in the management and prophylaxis of angina pectoris is given as 20 mg thrice daily in the conventional dosage regimen. The purpose of the present study was to formulate and evaluate twice a day extended release tablets containin...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications
2010
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3178970/ https://ncbi.nlm.nih.gov/pubmed/21969741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0250-474X.84578 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|